Opening Ceremony at SOLACI-CACI 2017 Congress

The largest Interventional Cardiology Congress in Latin America has already started. At Pacífico Room, Hilton Buenos Aires Hotel, the Scientific and Organizing Committee presented the objectives and contents for the next three intense days of scientific activity.

Opening Ceremony at SOLACI-CACI 2017 Congress
The first Congress activity was an international joint session with TCT.

The first Congress session was an international joint session with TCT.

 

Congress President Dr. Ruben Piraino highlighted the registration record of over 3000 attendees from all over the world. He also mentioned the 450 faculty members (425 from Latin America and 25 international guests) involved in the event and the 10 live cases, the 8 edited cases, round tables, lunch symposiums, and more, as the main attractions in this “unforgettable event.”

 

Dr. Fernando Cura and Dr. Alberto Sampaolesi (from the Scientific Committee) talked about a “need for a different kind of event, given the disparateness within the scientific audience, composed by both novice professionals and true experts in the field.” They also emphasized the crucial support received from the industry, without which no event of this magnitude could have been pulled off. Furthermore, they expressed their hope that “this work will result in growth for this specialty in this geographical region, higher benefits for patients, and, above all, an increase in the quality of cardiovascular health.”

 

SOLACI President Dr. Ricardo Lluberas mentioned that “the work carried out by the Scientific and Organizing Committee throughout this year was absolutely self-sacrificing. In consequence, once this Congress is over and we return to our homes, we will surely bring with us satisfaction derived from the fact that SOLACI-CACI 2017 will have effectively contributed to the strengthening of interventional cardiology in Latin America.”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors such as valve hemodynamic performance, durability, and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...